Patient Outcomes After Hepatic Artery Infusion Pump Placement

Completed

• Conditions: Colorectal Cancer; Colorectal Liver Metastases

• Registration Number: NCT05468593
• Lead Sponsor: Mayo Clinic

Brief Summary

The purpose of this study is to evaluate the surgical outcomes and the quality of life (QOL) in patients undergoing hepatic artery infusion pump placement for colorectal liver metastases (CRLM).

Detailed Description

Not available

Study Timeline

• Study Start: 2022-07-12
• Study First Submitted: 2022-07-12
• Study First Submitted QC: 2022-07-18
• Study First Posted: 2022-07-21
• Status Verified: 2024-07
• Primary Completion: 2024-07-01
• Study Completion: 2024-07-01
• Last Update Submitted: 2024-07-29
• Last Update Posted: 2024-07-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

• Patients who receive a Hepatic Artery Infusion Pump at Mayo Clinic Rochester for liver metastases from colorectal cancer.
• Written consent.

Read More

Exclusion Criteria

• Absence of written consent.
• Systemic disease.
• Pregnancy.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of Life	Postoperative day 180.	Self-reported quality of life and recovery from surgery using a questionnaire to investigate changes over time.

Secondary Outcome Measures

Name	Time	Method
Time to start chemotherapy	1 month postoperatively	Number of days following hepatic artery infusion pump placement until chemotherapy is started
Surgical outcomes	6 month postoperatively	Complications with hepatic artery infusion chemotherapy

Trial Locations

Locations (1)

Mayo Clinic Rochester; 🇺🇸 Rochester, Minnesota, United States